Investigate the inhibitor development rate of Human cl rhFVIII in previously untreated patients with severe Hemophilia A.
COMPLETED
Inclusion Criteria:
* Male patients
* Severe Hemophilia A (FVIII:C \<1%)
* No previous treatment with FVIII concentrates or other blood products containing FVIII
Exclusion Criteria:
* Diagnosis with a coagulation disorder other than Hemophilia A
* Severe liver or kidney disease
* Concomitant treatment with any systemic immunosuppressive drug
PHASE3
MALE
N/A
N/A
2021-01-19
N/A
BIOLOGICAL
Human cl rhFVIII
For more information and to contact the study team: